Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 37

Sort by

Sort Order Select

Journal Articles

Interleukin-8 inhibition by reparixin protects megakaryocytes and alleviates thrombocytopenia in Acute Myeloid Leukemia

Jing-Li Han, Meng-Yu Xiao, Jian-Ying Zhou, Ting Wang, Xiaolu Zhu, Hai-Xia Fu, Qian Jiang, Lan-Ping Xu, Xiaojun Huang, Xiaohui Zhang

Blood (2025) 146 (Supplement 1): 3235.

https://doi.org/10.1182/blood-2025-3235

Published: 2025

Journal Articles

Beyond the unknown: Leveraging machine learning to predict adverse outcomes in pregnant women with aplastic anemia from a representative nationwide cohort

Blood (2025) 146 (Supplement 1): 1413.

https://doi.org/10.1182/blood-2025-1413

Published: 2025

Journal Articles

Efficacy and safety of romiplostim N01 combined with cyclosporine in refractory aplastic anemia patients：a multicenter phase II study

Ting Wang, Lijuan Li, Huaquan Wang, Jia Song, Hui LIU, Yihao Wang, Liyan Li, Yue Ren, Rong Fu

Blood (2025) 146 (Supplement 1): 3195.

https://doi.org/10.1182/blood-2025-3195

Published: 2025

Journal Articles

Discrimination of Epstein–Barr virus latent infection and lytic replication reactivation using a novel methyl-CRISPR biosensor

Ting Wang, Guo-Ling Wang, Jingli Han, Lixin Wu, Yuanyuan Zhang, Hai-Xia Fu, Jia Feng, Hongyu Zhang, Xiaohui Zhang

Blood (2025) 146 (Supplement 1): 394.

https://doi.org/10.1182/blood-2025-394

Published: 2025

Journal Articles

Longitudinal immune reconstitution dynamics in refractory T-ALL treated with CD7 CAR-T cells bridging to allogeneic stem cell transplantation

Guo-Ling Wang, Han-Peng Luo, Ting Wang, Hai-Chan Xu, Li-Hua Sun, Bao-Zhen Qin, Hongyu Zhang, Jia Feng, Xiaohui Zhang

Blood (2025) 146 (Supplement 1): 3325.

https://doi.org/10.1182/blood-2025-3325

Published: 2025

Journal Articles

Pola-R-CHP in previously untreated low-risk (IPI 0-1) DLBCL: A nationwide multicenter retrospective study in China

Blood (2025) 146 (Supplement 1): 7229.

https://doi.org/10.1182/blood-2025-7229

Published: 2025

Journal Articles

Pola-Based Framework Regimen Treating DLBCL in Real World at Renji Hospital of China

Jun Du, Jue Wang, Zi-Yu Feng, Lan Xu, Fei Xiao, Jia Liu, Dan Xiao, Wan-Bin Fu, Min-Yue Zhang, Li-Jing Shen, Lu Zhong, Hua Zhong, Jian Hou, Hong-Hui Huang, Ting Wang

Blood (2024) 144 (Supplement 1): 7729.

https://doi.org/10.1182/blood-2024-206799

Published: 2024

Journal Articles

Efficacy and Safety of Venetoclax Combine Azacitidine for Acute Myeloid Leukemia in China: A Real-World Single-Center Study

Jiefei Bai, Hui Liu, Jiangtao Li, Ting Wang, Chunli Zhang, Yazi Yang, Xiaoya Yun, Jingjing Yin, Long Qian, Fei Zhao, Ru Feng, Hongmei Jing

Blood (2024) 144 (Supplement 1): 7896.

https://doi.org/10.1182/blood-2024-193714

Published: 2024

Journal Articles

Efficacy and Safety of Different TPO-RAs Combined with Cyclosporine in the Treatment of NSAA

Ting Wang, Donglan Liu, Nianbin Li, Shuai Gao, Lijuan Li, Jia Song, Huaquan Wang, Rong Fu

Blood (2024) 144 (Supplement 1): 5691.

https://doi.org/10.1182/blood-2024-209539

Published: 2024

Journal Articles

Dnmt3a Controls Hematopoietic Stem Cells Via DNA Methylation-Independent Regulation of Telomeres

Infencia Xavier Raj, Won Kyun Koh, Jessica Harrison, Christine RC Zhang, Barbara Soares, Aishwarya Krishnan, Hassan Bjeije, Tyler M Parsons, Wentao Han, Andrew L Young, Ting Wang, Luis Batista, Grant A Challen

Blood (2024) 144 (Supplement 1): 25.

https://doi.org/10.1182/blood-2024-203958

Published: 2024

Journal Articles

Polatuzumab Vedotin Plus Anti-CD20 Monoclonal Antibody and Dexamethasone in Previously Untreated Very Old/Frail Patients with Diffuse Large B-Cell Lymphoma

Xiaoya Yun, Jiefei Bai, Ru Feng, Jiangtao Li, Ting Wang, Yazi Yang, Jingjing Yin, Long Qian, Weidong Ding, Xiaoxuan Xue, Haoyu Qin, Hongmei Jing, Hui Liu

Blood (2024) 144 (Supplement 1): 6521.

https://doi.org/10.1182/blood-2024-203031

Published: 2024

Journal Articles

Tandem CAR-T-Cell Therapy Targeting CD5 and CD7: Facilitating Condition-Free Engraftment of Epitope-Edited Allogeneic HSCs

Guo-Ling Wang, Ting Wang, Jing-Li Han, Li-Xin Wu, Xuan-Zhong Chen, Zhuo-Yu An, Chen-Cong Wang, Peng Zhao, Lu-Lu Wang, Meng-Tong Zang, Wei Zheng, Hai-Xia Fu, Jia Feng, Hong-Yu Zhang, Xiaohui Zhang

Blood (2024) 144 (Supplement 1): 2041.

https://doi.org/10.1182/blood-2024-208043

Published: 2024

Journal Articles

Retrospective Analysis of Clinical Outcomes of Utilizing R-CHOP Plus Zanubrutinib for High-Risk Diffuse Large B Cell Lymphoma Patients with Extranodal Involvement or MYC/BCL2 Double Expression

Wanbin Fu, Jia Liu, Dan Xiao, Huanbin Zhao, Ting Wang, Jiong Hu, Jian Hou, Hua Zhong, Lan Xu

Blood (2023) 142 (Supplement 1): 6323.

https://doi.org/10.1182/blood-2023-182704

Published: 2023

Journal Articles

Mechanisms of Cytokine-Induced NK Cell Therapy: IL-12/15/18 Induce a Unique Transcriptional, Epigenetic, and Functional Human NK Cell Memory Program

Blood (2023) 142 (Supplement 1): 2067.

https://doi.org/10.1182/blood-2023-182435

Published: 2023

Journal Articles

Simplified Geriatric Assessment-Albumin: The Modified Tool for Older Diffuse Large B-Cell Lymphoma in China

Xiaoya Yun, Jiefei Bai, Ru Feng, Jiangtao Li, Ting Wang, Yazi Yang, Jingjing Yin, Long Qian, Shuai Zhang, Qingyun Cao, Xiaoxuan Xue, Hongmei Jing, Hui Liu

Blood (2023) 142 (Supplement 1): 1769.

https://doi.org/10.1182/blood-2023-184522

Published: 2023

Journal Articles

Zanubrutinib Plus Rituximab for the Treatment of Elderly Unfit Patients with Previously Untreated Diffuse Large-B Cell Lymphoma

Jiefei Bai, Jiangtao Li, Ru Feng, Long Qian, Jingjing Yin, Shuai Zhang, Ting Wang, Yazi Yang, Chunli Zhang, Jian Li, Hui Liu

Blood (2022) 140 (Supplement 1): 3748–3749.

https://doi.org/10.1182/blood-2022-168597

Published: 2022

Journal Articles

Phase I Study of a BCMA-Directed CAR-T Cell Therapy for Relapsed/Refractory Multiple Myeloma Manufactured in <3 Days Using the High-Performance Platform

Hui Liu, Ting Wang, Yazi Yang, Ru Feng, Jiangtao Li, Chunli Zhang, Jiefei Bai, Yanping Ding, Guanghua Liu, Fei Wu, Xinan Lu, Jian Li, Ting He

Blood (2022) 140 (Supplement 1): 10307–10308.

https://doi.org/10.1182/blood-2022-166011

Published: 2022

Journal Articles

IL-18 and IL-18 Binding Protein Are Related to Disease Severity of Myelodysplastic Syndromes

Ting Wang, Ningyuan Ran, Nianbin Li, Mengtong Zang, Xin He, Qiulin Chen, Zonghong Shao, Rong Fu

Blood (2022) 140 (Supplement 1): 12297.

https://doi.org/10.1182/blood-2022-168782

Published: 2022

Journal Articles

Phase I Study of a Novel Oral Proteasome Inhibitor TQB3602 in Relapsed/Refractory Multiple Myeloma

Wenjiao Tang, Yan Li, Qiushi Liang, Ying Qu, Li Zhang, Yuzhang Liu, Baijun Fang, Zeng Yun, Xiaobo Du, Yaming Xi, Ting Wang, Xin Li, Jie Huang, Wenbin Qian, Zhen Cai, Qingwei Zhao, Yue Lv, Ting Niu

Blood (2022) 140 (Supplement 1): 4396–4397.

https://doi.org/10.1182/blood-2022-168091

Published: 2022

Journal Articles

Evolution of Gilteritinib Resistance from Residual Disease to Relapse

Blood (2020) 136 (Supplement 1): 4–5.

https://doi.org/10.1182/blood-2020-139084

Published: 2020

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Interleukin-8 inhibition by reparixin protects megakaryocytes and alleviates thrombocytopenia in Acute Myeloid Leukemia

Beyond the unknown: Leveraging machine learning to predict adverse outcomes in pregnant women with aplastic anemia from a representative nationwide cohort

Efficacy and safety of romiplostim N01 combined with cyclosporine in refractory aplastic anemia patients：a multicenter phase II study

Discrimination of Epstein–Barr virus latent infection and lytic replication reactivation using a novel methyl-CRISPR biosensor

Longitudinal immune reconstitution dynamics in refractory T-ALL treated with CD7 CAR-T cells bridging to allogeneic stem cell transplantation

Pola-R-CHP in previously untreated low-risk (IPI 0-1) DLBCL: A nationwide multicenter retrospective study in China

Pola-Based Framework Regimen Treating DLBCL in Real World at Renji Hospital of China

Efficacy and Safety of Venetoclax Combine Azacitidine for Acute Myeloid Leukemia in China: A Real-World Single-Center Study

Efficacy and Safety of Different TPO-RAs Combined with Cyclosporine in the Treatment of NSAA

Dnmt3a Controls Hematopoietic Stem Cells Via DNA Methylation-Independent Regulation of Telomeres

Polatuzumab Vedotin Plus Anti-CD20 Monoclonal Antibody and Dexamethasone in Previously Untreated Very Old/Frail Patients with Diffuse Large B-Cell Lymphoma

Tandem CAR-T-Cell Therapy Targeting CD5 and CD7: Facilitating Condition-Free Engraftment of Epitope-Edited Allogeneic HSCs

Retrospective Analysis of Clinical Outcomes of Utilizing R-CHOP Plus Zanubrutinib for High-Risk Diffuse Large B Cell Lymphoma Patients with Extranodal Involvement or MYC/BCL2 Double Expression

Mechanisms of Cytokine-Induced NK Cell Therapy: IL-12/15/18 Induce a Unique Transcriptional, Epigenetic, and Functional Human NK Cell Memory Program

Simplified Geriatric Assessment-Albumin: The Modified Tool for Older Diffuse Large B-Cell Lymphoma in China

Zanubrutinib Plus Rituximab for the Treatment of Elderly Unfit Patients with Previously Untreated Diffuse Large-B Cell Lymphoma

Phase I Study of a BCMA-Directed CAR-T Cell Therapy for Relapsed/Refractory Multiple Myeloma Manufactured in <3 Days Using the High-Performance Platform

IL-18 and IL-18 Binding Protein Are Related to Disease Severity of Myelodysplastic Syndromes

Phase I Study of a Novel Oral Proteasome Inhibitor TQB3602 in Relapsed/Refractory Multiple Myeloma

Evolution of Gilteritinib Resistance from Residual Disease to Relapse

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only